Join hundreds of patients who have achieved lasting weight loss
A recent large-scale study involving people with a BMI over 30 found that these medications were linked to lower rates of heart disease, stroke, and kidney issues
As the weight loss drug market grows, some virtual care players seem to be competing on price
doi: 10.3389/fmed.2026.1764664 Received 10 December 2025 Revised 25 March 2026 Accepted 30 March 2026 Published 22 April 2026 Volume 13 - 2026 Edited by Isabella Panfoli, University of Genoa, Italy Reviewed by Raffaele Carraro, La Princesa University Hospital, Spain Kumar Ashish, CarolinaEast Medical Center, United States Updates Copyright 2026 Harbi, Ashour, Alorfi, Aldurdunji, Wali and Alzahrani
All currently available GLP-1 medications carry the same boxed warning regarding thyroid C-cell tumors based on animal studies, and none have demonstrated superiority or increased risk specifically in patients with autoimmune thyroid disease
CJC1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) , specifically engineered to increase your bodys natural production of growth hormone (GH) through the pituitary gland